Drug Company Leaders Condemn Ruling Invalidating F.D.A. Approval of Abortion Pill

Health
By BY CHRISTINA JEWETT from NYT Health https://ift.tt/Pj0gSu8
via IFTTT Drugs (Pharmaceuticals), Decisions and Verdicts, Abortion, Mifeprex (RU-486), Abortion Drugs, Biotechnology and Bioengineering More than 250 executives said that the decision ignored both scientific and legal precedent and, if it stands, would create uncertainty for the entire pharmaceutical and biotech industries.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda